• Citer

Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

par Bines, Jose;Procter, Marion;Restuccia, Eleonora;Viale, Giuseppe;Zardavas, Dimitros ;Suter, Thomas;Arahmani, Amal;van Dooren, Veerle;Baselga, José;Clark, Emma;Eng-Wong, Jennifer;Gelber, Richard;Piccart-Gebhart, Martine ;Mobus, Volker;de Azambuja, Evandro
Référence Clinical breast cancer
Publication Publié, 2020

Article révisé par les pairs

• Détails
• Contenu

Titre:	Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Auteur:	Bines, Jose; Procter, Marion; Restuccia, Eleonora; Viale, Giuseppe; Zardavas, Dimitros; Suter, Thomas; Arahmani, Amal; van Dooren, Veerle; Baselga, José; Clark, Emma; Eng-Wong, Jennifer; Gelber, Richard; Piccart-Gebhart, Martine; Mobus, Volker; de Azambuja, Evandro
Informations sur la publication:	Clinical breast cancer
Statut de publication:	Publié, 2020
Sujet CREF:	Cancérologie
Mots-clés:	Adjuvant
	Breast cancer
	Diarrhea
	HER2
	Pertuzumab
	Trastuzumab
Note générale:	SCOPUS: ar.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:1526-8209
	info:doi/10.1016/j.clbc.2019.06.016
	info:pii/S1526820919306561
	info:scp/85077653685